Detalles de la búsqueda
1.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
N Engl J Med;
389(20): 1851-1861, 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870969
2.
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
Lancet Oncol;
25(5): 588-602, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608691
3.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol;
25(5): 572-587, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561010
4.
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design.
Future Oncol;
20(12): 739-748, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197296
5.
Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck.
Jpn J Clin Oncol;
2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452121
6.
Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study.
J Oncol Pharm Pract;
30(2): 295-303, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098185
7.
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Cancer;
129(23): 3772-3782, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769113
8.
Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Int J Clin Oncol;
28(8): 1023-1032, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344738
9.
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial.
Cancer;
128(12): 2281-2287, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380178
10.
Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit.
Oncologist;
27(7): 565-572, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482606
11.
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
Oncologist;
27(2): e194-e198, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641218
12.
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Oncologist;
2022 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536733
13.
LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer.
Future Oncol;
18(28): 3143-3150, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969032
14.
Systemic therapy for salivary gland malignancy: current status and future perspectives.
Jpn J Clin Oncol;
52(4): 293-302, 2022 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35134985
15.
Human papillomavirus-related oropharyngeal carcinoma.
Jpn J Clin Oncol;
52(7): 700-706, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35383359
16.
Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer.
Int J Clin Oncol;
27(11): 1669-1674, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943644
17.
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lancet Oncol;
22(4): 450-462, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794205
18.
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
Jpn J Clin Oncol;
51(2): 199-204, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147611
19.
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
Jpn J Clin Oncol;
51(2): 173-179, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33290543
20.
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance.
Int J Clin Oncol;
26(9): 1619-1627, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110532